A recommended analysis for 2 x 2 crossover trials with baseline measurements

Pharmaceutical Statistics

Volumn 13, Issue 6, 2014, Pages 376-387

  Mehrotra, Devan V ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Baseline adjustment; Covariance structure; Covariate; Crossover trial; Kenward Roger degrees of freedom

Indexed keywords

ARTICLE; BLOOD PRESSURE MONITORING; CROSSOVER PROCEDURE; DEPENDENT VARIABLE; HUMAN; MATHEMATICAL MODEL; MAXIMUM LIKELIHOOD METHOD; MEAN ARTERIAL PRESSURE; MEASUREMENT; NULL HYPOTHESIS; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT RESPONSE; CLINICAL TRIAL (TOPIC); PROCEDURES; STATISTICS AND NUMERICAL DATA;

CLINICAL TRIALS AS TOPIC; CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL; HUMANS;

EID: 84911965511     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1638     Document Type: Article

References (17)

1. Hills M, Armitage P. The two-period cross-over clinical trial. British Journal of Clinical Pharmacology 1979; 8:7-20.
2. Armitage P, Hills M. The two-period crossover trial. The Statistician 1982; 31:119-131.
3. Patel H I. Use of baselinemeasurements in the two-period crossover design. Communications in Statistics-Theory and Methods 1983; 12:2693-2712.
4. Castellana J V, Patel H I. Analysis of two-period crossover design in a multicenter clinical trial. Biometrics 1985; 41:969-977.
5. Wallenstein S. Analysis of the crossover design with baseline. American Statistical Association, Proceedings of the Biopharmaceutical Section, 1986; pp. 157-160.
6. Willan A R, Pater J L. Using baselinemeasurements in the two period cross-over trial. Controlled Clinical Trials 1986; 7:282-289.
7. Kenward M G, Jones B. The analysis of data from 2 2 cross-over trials with baseline measurements. Statistics in Medicine 1987; 6:911-926.
8. Senn S J. Cross-Over Trials in Clinical Research. JohnWiley: Chichester, 1993.
9. Kenward M G, Roger J H. The analysis of data from 2 2 cross over trials with baseline measurements. Biostatistics 2010; 11:1-17.
10. Metcalfe C. The analysis of cross-over trials with baseline measurements. Statistics in Medicine 2010; 29:3211-3218.
11. Chen X, Meng Z, Zhang J. Handling of baseline measurements in the analysis of crossover trials. Statistics in Medicine 2012; 31: 1791-1803.
12. Yan Z. The impact of baseline covariates on the efficiency of statistical analyses of crossover designs. Statistics in Medicine 2013; 32:956-963.
13. Matthews J N S, Henderson R. Two-period, two-treatment crossover designs subject to non-ignorable missing data. Biostatistics 2013; 14:626-638. DOI: 10.1093/biostatistics/kxt009.
14. Rosenkranz G K. Analysis of crossover studies with missing data. Statistical Methods in Medical Research 2014 (published online). DOI: 10.1177/0962280214521349.
15. Hurvich C M, Tsai C L. Regression and time seriesmodel selection in small samples. Biometrika 1989; 76:297-307.
16. Kenward M G, Roger J H. Small sample inference for fixed effects estimators from restricted maximum likelihood. Biometrics 1997; 53:983-997.
17. Dupont W D, Plummer W D. PS power and sample size program available for free on the Internet. Controlled Clinical Trials 1997; 18:274.